In 2023, the imports of medicinal and pharmaceutical products in the Philippines were recorded at value '1.7' (expressed in Constant 2018). Forecasts indicate a steady increase to '1.8' in 2024 and '1.9' from 2025 through 2028. This represents an overall increase from 2023 to 2024 of approximately 5.88%, followed by a year-on-year increase of 5.56% from 2024 to 2025. The imports are expected to stabilize from 2025 onward, maintaining a constant value of 1.9 till 2028. The compound annual growth rate (CAGR) over the five-year period from 2023 to 2028 is approximately 2.26%.
Future trends to watch for:
• Potential shifts in global supply chains that might affect the availability and price of medicinal and pharmaceutical products.
• Policy changes or government initiatives in the Philippines aimed at boosting domestic pharmaceutical manufacturing, which could impact import levels.
• Technological advancements in pharmaceuticals and new medical treatments that may drive demand for specific imported products.
• Economic factors and their influence on healthcare spending and pharmaceutical imports.
